Human Genome Epidemiology Literature Finder
|
Records 1 - 21 (of 21 Records) |
| Query Trace: Disease Progression and ERBB2[original query] |
|---|
| Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients. Breast cancer research and treatment 2015 Dec . Liang Diana H, Ensor Joe E, Liu Zhe-Bin, Patel Asmita, Patel Tejal A, Chang Jenny C, Rodriguez Angel |
| Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis. Acta cytologica 2017 May . Rodriguez Erika F, Shabihkhani Maryam, Carter Jamal, Maleki Zah |
| Mutation Detection in Tumor-Derived Cell Free DNA Anticipates Progression in a Patient With Metastatic Colorectal Cancer. Frontiers in oncology 2018 8 8 306. de Figueiredo Barros Bruna D, Kupper Bruna E C, Aguiar Junior Samuel, de Mello Celso A L, Begnami Maria D, Chojniak Rubens, de Souza Sandro J, Torrezan Giovana T, Carraro Dirce |
| EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis. Urologic oncology 2019 01 37 (1): 71-77. Huang Kang-Bo, Liu Ran-Yi, Peng Qi-Hua, Li Zai-Shang, Jiang Li-Juan, Guo Sheng-Jie, Zhou Qiang-Hua, Liu Ting-Yu, Deng Chuang-Zhong, Yao Kai, Qin Zi-Ke, Liu Zhuo-Wei, Li Yong-Hong, Han Hui, Zhou Fang-Ji |
| Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA. The oncologist 2019 4 24 (8): 1022-1026. Otsubo Kohei, Sakai Kazuko, Takeshita Masafumi, Harada Daijiro, Azuma Koichi, Ota Keiichi, Akamatsu Hiroaki, Goto Koichi, Horiike Atsushi, Kurata Takayasu, Nakagaki Noriaki, Nosaki Kaname, Iwama Eiji, Nakanishi Yoichi, Nishio Kazuto, Okamoto Isa |
| Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer. Diagnostics (Basel, Switzerland) 2020 Jul 10 (8): . Niwinska Anna, Ba?abas Aneta, Kulecka Maria, Kluska Anna, Pi?tkowska Magdalena, Paziewska Agnieszka, Py?niak Kazimiera, Olszewski Wojciech, Mikula Micha?, Ostrowski Jer |
| Effect of Capivasertib in Patients With an AKT1 E17K-Mutated Tumor: NCI-MATCH Subprotocol EAY131-Y Nonrandomized Trial. JAMA oncology 2020 12 7 (2): 271-278. Kalinsky Kevin, Hong Fangxin, McCourt Carolyn K, Sachdev Jasgit C, Mitchell Edith P, Zwiebel James A, Doyle L Austin, McShane Lisa M, Li Shuli, Gray Robert J, Rubinstein Larry V, Patton David, Williams Paul M, Hamilton Stanley R, Conley Barbara A, O'Dwyer Peter J, Harris Lyndsay N, Arteaga Carlos L, Chen Alice P, Flaherty Keith |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib. Scientific reports 2020 1 10 (1): 691. Ishii Hidenobu, Azuma Koichi, Sakai Kazuko, Naito Yoshiko, Matsuo Norikazu, Tokito Takaaki, Yamada Kazuhiko, Hoshino Tomoaki, Nishio Kazu |
| TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer. PeerJ 2021 5 9 e11146. Li Jia, Li Zhaoyan, Ding Yajie, Xu Yan, Zhu Xiaohong, Cao Nida, Huang Chen, Qin Mengmeng, Liu Feng, Zhao Aigua |
| Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity. Scientific reports 2021 5 11 (1): 10571. Phung Tanya N, Webster Timothy H, Lenkiewicz Elizabeth, Malasi Smriti, Andreozzi Mariacarla, McCullough Ann E, Anderson Karen S, Pockaj Barbara A, Wilson Melissa A, Barrett Michael |
| Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer. Frontiers in oncology 2021 3 11 588136. Tian Chonglin, Liu Sujing, Wang Yongsheng, Song Xianra |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 2 35 (8): 1066-1074. Stradella Agostina, Gargallo Pablo, Cejuela Mónica, Petit Anna, Bosch-Schips Jan, Carbonell Paula, Recalde Sabela, Vethencourt Andrea, Fernandez-Ortega Adela, Falo Catalina, Gil-Gil Miguel, Vázquez Silvia, Obadia Verónica, Villanueva-Vázquez Rafael, Soler-Monsó Teresa, Calabria Inés, Pernas Son |
| Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy. Yonsei medical journal 2023 8 64 (9): 531-540. Seung-Hyun Jung, Choong-Kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jun Chung, Sun Young R |
| ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
- Page last reviewed:Feb 1, 2024
- Content source: